Lupus Science & Medicine

Lectin pathway of complement in SLE: MAP-1 as a marker of haematological manifestations and elevated type I interferon activity

Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
Lupus Science & Medicine

Conditions identified by common comprehensive geriatric assessment measures and subsequent acute care among adults with SLE

Objective The value of comprehensive geriatric assessment (CGA) in the setting of chronic disease, regardless of age, has ...
lupus.bmj

Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational ...

Objectives Systemic lupus erythematosus (SLE) is a disease with heterogeneous treatment patterns largely based on organ involvement and disease severity. The SLE Prospective Observational Cohort Study ...
lupus.bmj

P24 Differentiated monocytes express the pDC markers BDCA-2 and CD123

Objective Plasmacytoid dendritic cells (pDCs) were previously thought to be the major source of type I interferon in SLE. BDCA-2 appears to be exclusively expressed on pDCs in fresh blood and has been ...